Skip to main content

and
  1. Article

    Open Access

    The influence of marital status at diagnosis on survival of adult patients with mantle cell lymphoma

    Marital status has been reported to influence the survival outcomes of various cancers, but its impact on patients with mantle cell lymphoma (MCL) remains unclear. This study aimed to assess the influence of m...

    Ting Zhang, Zhao-tong Wang, Zhuo Li in Journal of Cancer Research and Clinical On… (2024)

  2. Article

    Open Access

    MET amplification identified by next-generation sequencing and its clinical relevance for MET inhibitors

    MET amplification plays an important role in the development of non-small-cell lung cancer (NSCLC) either de novo or in resistance to epidermal growth factor receptor tyrosine–kinase inhibitor (EGFR-TKI) settings...

    Lun-** Peng, Guang-Ling Jie, An-Na Li, Si-Yang Liu in Experimental Hematology & Oncology (2021)

  3. No Access

    Article

    Application of Perioperative Transfusion Trigger Score in Patients Undergoing Surgical Treatment of Malignant Tumor

    The present study aimed to investigate the clinical effects of the brand new perioperative transfusion trigger score (POTTS) system in patients undergoing malignant tumor surgeries. 442 cases of patients diagn...

    Fan Zhang, Ze-Bing Zheng, Zhao-Qiong Zhu in Indian Journal of Hematology and Blood Tra… (2020)

  4. Article

    Open Access

    Emerging therapies for non-small cell lung cancer

    Recent advances in the field of novel anticancer agents prolong patients’ survival and show a promising future. Tyrosine kinase inhibitors and immunotherapy for lung cancer are the two major areas undergoing r...

    Chao Zhang, Natasha B. Leighl, Yi-Long Wu in Journal of Hematology & Oncology (2019)

  5. Article

    Open Access

    Serial cfDNA assessment of response and resistance to EGFR-TKI for patients with EGFR-L858R mutant lung cancer from a prospective clinical trial

    Detecting epidermal growth factor receptor (EGFR) activating mutations in plasma could guide EGFR-tyrosine kinase inhibitor (EGFR-TKI) treatment for advanced non-small cell lung cancer (NSCLC). However, dynamic q...

    Qing Zhou, **-Ji Yang, Zhi-Hong Chen, Xu-Chao Zhang in Journal of Hematology & Oncology (2016)

  6. No Access

    Article

    Wharton’s Jelly-derived mesenchymal stem cells alleviate memory deficits and reduce amyloid-β deposition in an APP/PS1 transgenic mouse model

    Alzheimer’s disease (AD) is the leading cause of dementia in the elderly and is characterized by amyloid plaques, neurofibrillary tangles, and neuronal loss. Cumulative evidence supports that neuroinflammation...

    Zhao-Hong **e, Zhen Liu, **ao-Ran Zhang, Hui Yang in Clinical and Experimental Medicine (2016)

  7. No Access

    Article

    Decreased expression of myosin light chain MYL9 in stroma predicts malignant progression and poor biochemical recurrence-free survival in prostate cancer

    The aim of this study was to investigate the associations of myosin light chain (MYL9) downregulation with tumor progression and prognosis in patients with prostate cancer (PCa). MYL9 protein expression in hu...

    Ya-qiang Huang, Zhao-dong Han, Yu-xiang Liang, Zhuo-yuan Lin in Medical Oncology (2013)

  8. No Access

    Article

    Enhanced production of CTGF and IL-11 from highly metastatic hepatoma cells under hypoxic conditions: an implication of hepatocellular carcinoma metastasis to bone

    The biology underlying bone-specific metastasis (BM) of hepatocellular carcinoma (HCC) is poorly understood. The goal of the present study is to further elucidate the molecular and cellular mechanisms underlyi...

    Ya-Bo Gao, Zuo-Lin **ang, Le-Yuan Zhou in Journal of Cancer Research and Clinical On… (2013)

  9. No Access

    Article

    Identification of novel serological tumor markers for human prostate cancer using integrative transcriptome and proteome analysis

    The aim of this study was to identify novel serological tumor markers for human prostate cancer (PCa). We compared the gene expression profile of PCa tissues to adjacent benign tissues of prostate using gene e...

    Zhao-dong Han, Yan-qiong Zhang, Hui-chan He, Qi-shan Dai, Guo-qiang Qin in Medical Oncology (2012)

  10. No Access

    Article

    A clinicopathological model to predict bone metastasis in hepatocellular carcinoma

    We aimed to develop a clinicopathological model that would predict the risk of bone metastasis (BM) in hepatocellular carcinoma (HCC).

    Zuo-Lin **ang, Zhao-Chong Zeng, Jia Fan in Journal of Cancer Research and Clinical On… (2011)

  11. No Access

    Article

    Benefit of radiotherapy for 90 patients with resected intrahepatic cholangiocarcinoma and concurrent lymph node metastases

    To evaluate the role of radiotherapy for patients with resected intrahepatic cholangiocarcinoma with concurrent macroscopic abdominal lymph node metastases.

    Wei Jiang, Zhao-Chong Zeng, Zhao-You Tang in Journal of Cancer Research and Clinical On… (2010)

  12. No Access

    Article

    CK20 and Ki-67 as significant prognostic factors in human bladder carcinoma

    Aberrant expression of CK20 and Ki-67 has been documented in many kinds of primary tumors and has proved useful as an ancillary diagnostic aid for those tumors. The aim of this study was to analyze the express...

    Yong-kang Ye, Xue-cheng Bi, Hui-chan He in Clinical and Experimental Medicine (2010)

  13. No Access

    Article

    Real-time quantitative RT-PCR assessment of PIM-1 and hK2 mRNA expression in benign prostate hyperplasia and prostate cancer

    To investigate the expressions of PIM-1 and hK2 mRNA in normal prostate, benign prostatic glandular hyperplasia (BPH), and prostate cancer (PCa), and to explore the association of PIM-1 and hK2 expressions wit...

    Hui-chan He, Xue-cheng Bi, Zhi-wei Zheng, Qi-shan Dai, Zhao-Dong Han in Medical Oncology (2009)

  14. No Access

    Article

    Improved long-term survival for unresectable hepatocellular carcinoma (HCC) with a combination of surgery and intrahepatic arterial infusion of 131I-anti-HCC mAb. Phase I/II clinical trials

    Resectional therapy has been accepted as the only curative therapy for hepatocellular carcinoma (HCC). Unfortunately, it is estimated that only 10% of HCC are resectable at the time of diagnosis. Cytoreductio...

    Zhao-Chong Zeng, Zhao-You Tang, Kang-Da Liu in Journal of Cancer Research and Clinical On… (1998)

  15. No Access

    Article

    Radioimmunotherapy for unresectable hepatocellular carcinoma using131I-Hepama-1 mAb: preliminary results

    Twenty-three patients with surgically verified unresectable hepatocellular carcinoma (HCC) have been treated by intrahepatic arterial administration of131I-labeled anti-HCC monoclonal antibody (Hepama-1) combined...

    Zhao-Chong Zeng, Zhao-You Tang, Hong **e in Journal of Cancer Research and Clinical On… (1993)